Funding

The Epigenetic Etiology of Human Disease Lab at Mayo Clinic receives ongoing research support from several institutes of the National Institutes of Health.

Grants

Investigator & Role Grant Title Funding Source Duration
Keith D. Robertson, Ph.D., principal investigator Epigenetic heterogeneity as a driver of liver disease and cancer (R01 AA27179) National Institute on Alcohol Abuse and Alcoholism 08/16/2018-05/31/2023
Keith D. Robertson, Ph.D., principal investigator Deciphering the interplay between H3K36 and DNA methylation in renal cancer (R01 CA224917) National Cancer Institute 04/03/2018-03/31/2023
Keith D. Robertson, Ph.D., principal investigator Epigenetic mechanisms underlying hepatitis C-induced hepatocarcinogenesis (R01 DK110024) National Institute of Diabetes and Digestive and Kidney Diseases 09/01/2017-06/30/2021